Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.

Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.

Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65. doi: 10.1016/j.euroneuro.2009.01.015. Epub 2009 Apr 2.

PMID:
19345072
[PubMed - indexed for MEDLINE]
2.

A risk-benefit assessment of mirtazapine in the treatment of depression.

Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.

Drug Saf. 1997 Oct;17(4):251-64. Review. Erratum in: Drug Saf 1998 Feb;18(2):123.

PMID:
9352961
[PubMed - indexed for MEDLINE]
3.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

PMID:
10446737
[PubMed - indexed for MEDLINE]
4.

[Therapeutic action lag time and resistance to treatment].

Peretti CS.

Encephale. 1999 Jun;25 Spec No 2:49-54. Review. French.

PMID:
10434159
[PubMed - indexed for MEDLINE]
5.

Mirtazapine: a review of its use in major depression and other psychiatric disorders.

Croom KF, Perry CM, Plosker GL.

CNS Drugs. 2009;23(5):427-52. doi: 10.2165/00023210-200923050-00006. Review.

PMID:
19453203
[PubMed - indexed for MEDLINE]
6.

[Severe forms of depression: the efficacy of escitalopram].

Spadone C.

Encephale. 2009 Apr;35(2):152-9. doi: 10.1016/j.encep.2008.09.008. Epub 2009 Mar 31. Review. French.

PMID:
19393384
[PubMed - indexed for MEDLINE]
7.

An overview of the clinical efficacy of mirtazapine.

Benkert O, Muller M, Szegedi A.

Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S23-6. Review.

PMID:
12404666
[PubMed - indexed for MEDLINE]
8.

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group.

J Clin Psychiatry. 2008 Sep;69(9):1404-15. Review.

PMID:
19193341
[PubMed - indexed for MEDLINE]
9.

Mirtazapine: a review of its use in major depression.

Holm KJ, Markham A.

Drugs. 1999 Apr;57(4):607-31. Review.

PMID:
10235695
[PubMed - indexed for MEDLINE]
10.

Mirtazapine, an antidepressant.

Puzantian T.

Am J Health Syst Pharm. 1998 Jan 1;55(1):44-9. Review.

PMID:
9437474
[PubMed - indexed for MEDLINE]
11.

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

Montgomery SA, Möller HJ.

Int Clin Psychopharmacol. 2009 May;24(3):111-8. doi: 10.1097/YIC.0b013e32832a8eb2. Review.

PMID:
19357527
[PubMed - indexed for MEDLINE]
12.

Antidepressant combination for major depression in incomplete responders--a systematic review.

Lopes Rocha F, Fuzikawa C, Riera R, Ramos MG, Hara C.

J Affect Disord. 2013 Jan 10;144(1-2):1-6. doi: 10.1016/j.jad.2012.04.048. Epub 2012 Jul 24. Review.

PMID:
22835845
[PubMed - indexed for MEDLINE]
13.

Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.

Bobo WV, Shelton RC.

Expert Opin Pharmacother. 2009 Sep;10(13):2145-59. doi: 10.1517/14656560903130609. Review.

PMID:
19640209
[PubMed - indexed for MEDLINE]
14.

Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials.

Serretti A, Gibiino S, Drago A.

J Affect Disord. 2011 Jul;132(1-2):14-25. doi: 10.1016/j.jad.2010.08.018. Epub 2010 Sep 21. Review.

PMID:
20863574
[PubMed - indexed for MEDLINE]
15.

Mirtazapine. A pharmacoeconomic review of its use in depression.

Holm KJ, Jarvis B, Foster RH.

Pharmacoeconomics. 2000 May;17(5):515-34. Review.

PMID:
10977391
[PubMed - indexed for MEDLINE]
16.

New formulations of existing antidepressants: advantages in the management of depression.

Norman TR, Olver JS.

CNS Drugs. 2004;18(8):505-20. Review.

PMID:
15182220
[PubMed - indexed for MEDLINE]
17.

Major depressive disorder, antidepressants, and sexual dysfunction.

Clayton AH, Montejo AL.

J Clin Psychiatry. 2006;67 Suppl 6:33-7. Review.

PMID:
16848675
[PubMed - indexed for MEDLINE]
18.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
19.

Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis.

Katzman MA, Tricco AC, McIntosh D, Filteau MJ, Bleau P, Chokka PR, Kjernisted KD, Mok H, Pham B.

J Clin Psychiatry. 2007 Dec;68(12):1845-59. Review.

PMID:
18162015
[PubMed - indexed for MEDLINE]
20.

Venlafaxine XR therapy for major depression and anxiety disorders. The clinical implications that its advantages pose.

Sussman N.

Postgrad Med. 1999 Nov;106(6 Suppl):31-6. doi: 10.3810/pgm.11.1999.suppl1.5. Review.

PMID:
19667502
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk